CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Small business owners can enhance their wealth with smart strategies. Learn how to grow your assets effectively.
21,863 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Nike is flirting with a comeback narrative as it gears up for June earnings. This guide breaks down what to watch, ho...
Public fallout can shake more than your reputation—it can reshape your finances and family security. This article use...
A major fund recently added a sizable Mosaic position, highlighting growing interest in fertilizer stocks as potash p...
USA Rare Earth's stock sprinted higher even as broader markets slipped. A major asset deal and clear production miles...
Fantasy Top captivated Crypto Twitter with a fresh take on fantasy sports powered by blockchain. Now, after two years...
Anthropic’s Boris Cherny says he oversees a growing fleet of AI agents, signaling a dramatic shift in software develo...
A new Fed chair angles for a disciplined inflation fight and a leaner balance sheet, even as markets seek clarity. He...
As of July 16, 2026, Brent crude sits around $84.64 per barrel, easing slightly after yesterday’s pullback. The curre...
Flotek's 2025 earnings outlook hinges on energy demand, cost control, and segment mix. This guide breaks down what to...
A high-level U.S. trip to Havana signals renewed talks on economics and security. The director traveled cuba with a c...
A renowned artist and philanthropist reveals a different dream: winemaking. This article turns that tale into practic...